Panzyga 100 mg/ml Infusionslösung, Isotone Kochsalz-Lösung 0,9 % Braun Infusionslösung
NGAM-16
Phase 3 small_molecule active
Quick answer
Panzyga 100 mg/ml Infusionslösung, Isotone Kochsalz-Lösung 0,9 % Braun Infusionslösung for Prevention of a Major infection in patients with Hypogammaglobulinemia and Autoimmune or Rheumatic Conditions receiving treatment with B-cell depletion therapy. is a Phase 3 program (small_molecule) at Maze Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Maze Therapeutics
- Indication
- Prevention of a Major infection in patients with Hypogammaglobulinemia and Autoimmune or Rheumatic Conditions receiving treatment with B-cell depletion therapy.
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active